Iovance Biotherapeutics I... (IOVA)
NASDAQ: IOVA
· Real-Time Price · USD
2.49
-0.06 (-2.35%)
At close: Aug 18, 2025, 3:59 PM
2.81
12.85%
After-hours: Aug 18, 2025, 06:41 PM EDT
Iovance Biotherapeutics Revenue
Iovance Biotherapeutics reported an annual revenue of $164.07M, reflecting a 13698.99% growth. For the quarter ending June 30, 2025, Iovance Biotherapeutics generated $59.95M in revenue.
Revenue (ttm)
164.07M
Revenue Growth
13698.99%
Price / Sales Ratio
13.07
Revenue / Employee
195.79K
Employees
838
Market Cap
901.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 164.07M | +13698.99% |
| Dec 31, 2023 | 1.19M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |
| Dec 31, 2011 | 0 | n/a |
| Dec 31, 2010 | 0 | n/a |
| Dec 31, 2009 | 0 | n/a |
| Dec 31, 2008 | 0 | n/a |